Macclesfield, United Kingdom

Lyn Powell




Average Co-Inventor Count = 3.6

ph-index = 3

Forward Citations = 21(Granted Patents)


Location History:

  • Cheshire, GB (1995)
  • Macclesfield, GB (1990 - 2012)

Company Filing History:


Years Active: 1990-2012

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Lyn Powell: Innovator in Chemical Processes

Introduction

Lyn Powell is a distinguished inventor based in Macclesfield, GB. She has made significant contributions to the field of chemical processes, holding a total of 8 patents. Her work primarily focuses on the development of pharmaceutical compounds and their manufacturing processes.

Latest Patents

Among her latest patents is a groundbreaking invention related to the crystalline forms of 4-(6-chloro-2,3-methylenedioxyanilino)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-tetrahydropyran-4-yloxyquinazoline. This invention pertains to chemical processes useful in the manufacture of this compound, which is the active entity within AZD0530. It also includes the development of particular crystalline forms of the compound, such as a difumarate salt and a trihydrate, along with pharmaceutical compositions containing these forms. Another notable patent involves a process for the preparation of novel pyridopyrazines as mTOR kinase inhibitors, which outlines the use of specific compounds in therapeutic compositions.

Career Highlights

Lyn Powell has had a remarkable career, working with prominent companies such as Imperial Chemical Industries Limited and Zeneca Limited. Her expertise in chemical processes has led to innovative solutions in the pharmaceutical industry.

Collaborations

Throughout her career, Lyn has collaborated with notable colleagues, including Andrew Peter Thomas and David M Martin. These partnerships have contributed to her success and the advancement of her inventions.

Conclusion

Lyn Powell's contributions to the field of chemical processes and her innovative patents highlight her role as a leading inventor. Her work continues to impact the pharmaceutical industry positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…